A TNFRSF14-FcɛRI-mast cell pathway contributes to development of multiple features of asthma pathology in mice - Inserm - Institut national de la santé et de la recherche médicale
Article Dans Une Revue Nature Communications Année : 2016

A TNFRSF14-FcɛRI-mast cell pathway contributes to development of multiple features of asthma pathology in mice

Nicolas Gaudenzio

Résumé

Asthma has multiple features, including airway hyperreactivity, inflammation and remodelling. The TNF superfamily member TNFSF14 (LIGHT), via interactions with the receptor TNFRSF14 (HVEM), can support TH2 cell generation and longevity and promote airway remodelling in mouse models of asthma, but the mechanisms by which TNFSF14 functions in this setting are incompletely understood. Here we find that mouse and human mast cells (MCs) express TNFRSF14 and that TNFSF14:TNFRSF14 interactions can enhance IgE-mediated MC signalling and mediator production. In mouse models of asthma, TNFRSF14 blockade with a neutralizing antibody administered after antigen sensitization, or genetic deletion of Tnfrsf14, diminishes plasma levels of antigen-specific IgG1 and IgE antibodies, airway hyperreactivity, airway inflammation and airway remodelling. Finally, by analysing two types of genetically MC-deficient mice after engrafting MCs that either do or do not express TNFRSF14, we show that TNFRSF14 expression on MCs significantly contributes to the development of multiple features of asthma pathology.
Fichier principal
Vignette du fichier
2016_Sibliano.pdf (2.29 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03521499 , version 1 (11-01-2022)

Licence

Identifiants

Citer

Riccardo Sibilano, Nicolas Gaudenzio, Marianne K Degorter, Laurent L Reber, Joseph D Hernandez, et al.. A TNFRSF14-FcɛRI-mast cell pathway contributes to development of multiple features of asthma pathology in mice. Nature Communications, 2016, 7, pp.13696. ⟨10.1038/ncomms13696⟩. ⟨hal-03521499⟩
30 Consultations
23 Téléchargements

Altmetric

Partager

More